Quick Answer
Sonoma Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $5.37 million for the year ending 2025.
- Sonoma Pharmaceuticals, Inc. showed an increase of +71.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Sonoma Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on June 17, 2025.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $7.90 million | Q2 2013: $5.38 million | Q3 2013: $3.19 million | Q4 2013: $3.44 million | Q2 2014: $4.99 million | Q3 2014: $3.55 million | Q4 2014: $2.24 million | Q2 2015: $8.75 million | Q3 2015: $7.97 million | Q4 2015: $6.11 million | Q2 2016: $4.97 million | Q3 2016: $3.25 million | Q4 2016: $18.98 million | Q2 2017: $12.64 million | Q3 2017: $9.98 million | Q4 2017: $8.63 million | Q2 2018: $7.69 million | Q3 2018: $4.05 million | Q4 2018: $6.50 million | Q2 2019: $4.28 million | Q3 2019: $3.23 million | Q4 2019: $3.73 million | Q1 2020: $3.69 million | Q2 2020: $4.55 million | Q3 2020: $4.32 million | Q4 2020: $5.54 million | Q2 2021: $2.81 million | Q3 2021: $8.39 million | Q4 2021: $8.53 million | Q2 2022: $5.59 million | Q3 2022: $3.35 million | Q4 2022: $2.63 million | Q2 2023: $3.54 million | Q3 2023: $2.14 million | Q4 2023: $2.41 million | Q2 2024: $2.59 million | Q3 2024: $4.08 million | Q4 2024: $5.24 million | Q1 2025: $5.37 million | Q2 2025: $3.61 million | Q3 2025: $3.04 million | Q4 2025: $2.56 million.
- Over the full 16 years of available data (2010 to 2025), Sonoma Pharmaceuticals, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 14.1%.
- Historical annual values: Fiscal year 2025: $5.37 million | Fiscal year 2024: $3.13 million | Fiscal year 2023: $3.82 million | Fiscal year 2022: $7.40 million | Fiscal year 2021: $4.22 million | Fiscal year 2020: $3.69 million | Fiscal year 2019: $3.69 million | Fiscal year 2018: $10.07 million | Fiscal year 2017: $17.46 million | Fiscal year 2016: $7.47 million | Fiscal year 2015: $6.14 million | Fiscal year 2014: $5.48 million | Fiscal year 2013: $7.90 million | Fiscal year 2012: $3.35 million | Fiscal year 2011: $4.37 million | Fiscal year 2010: $6.26 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: